Cargando…

Prefilled syringes and usability of ophthalmic viscosurgical devices

PURPOSE: To examine the influence of the configuration of prefilled syringes on the usability of ophthalmic viscosurgical devices (OVDs). SETTING: Department of Ophthalmology, Jikei University School of Medicine, Tokyo, Japan. DESIGN: Experimental study. METHODS: The maximum force needed to extrude...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiba, Takuya, Tsuneoka, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160326/
https://www.ncbi.nlm.nih.gov/pubmed/25228786
http://dx.doi.org/10.2147/OPTH.S67689
_version_ 1782334385670848512
author Shiba, Takuya
Tsuneoka, Hiroshi
author_facet Shiba, Takuya
Tsuneoka, Hiroshi
author_sort Shiba, Takuya
collection PubMed
description PURPOSE: To examine the influence of the configuration of prefilled syringes on the usability of ophthalmic viscosurgical devices (OVDs). SETTING: Department of Ophthalmology, Jikei University School of Medicine, Tokyo, Japan. DESIGN: Experimental study. METHODS: The maximum force needed to extrude the whole OVD (extrusion force) was compared among viscous cohesive OVDs (OPEGAN Hi(®) 0.85 mL and Healon(®) 0.85 mL) and very low viscosity dispersive OVDs (OPEGAN(®) 0.6 mL and OPEGAN(®) 1.1 mL). Additionally, to exclude the influence of any differences between syringes of viscous cohesive OVDs on the extrusion force, empty syringes of the same configuration were refilled with the same products. In addition, the syringe inner surface and that of the piston attached to the tip of the plunger were measured. RESULTS: The extrusion force of Healon 0.85 mL (3.28±0.19 kgf) was significantly (P<0.01) higher than that of OPEGAN Hi 0.85 mL (2.54±0.23 kgf). The inner syringe chamber for Healon 0.85 mL was vial shaped and had a built-in needle in the Luer tip, which was clearly different from OPEGAN Hi 0.85 mL. There were no significant differences in the extrusion force between refilled syringes. The extrusion force of OPEGAN 1.1 mL (3.44±0.12 kgf) was significantly (P<0.01) higher than that of OPEGAN 0.6 mL (1.63±0.06 kgf). The syringe of OPEGAN 1.1 mL was obviously bigger than that of OPEGAN 0.6 mL. CONCLUSION: It was confirmed that the configuration of the syringes is another determinant of the extrusion force and a factor related to the difference in usability among products that meet the same cohesive class.
format Online
Article
Text
id pubmed-4160326
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-41603262014-09-16 Prefilled syringes and usability of ophthalmic viscosurgical devices Shiba, Takuya Tsuneoka, Hiroshi Clin Ophthalmol Original Research PURPOSE: To examine the influence of the configuration of prefilled syringes on the usability of ophthalmic viscosurgical devices (OVDs). SETTING: Department of Ophthalmology, Jikei University School of Medicine, Tokyo, Japan. DESIGN: Experimental study. METHODS: The maximum force needed to extrude the whole OVD (extrusion force) was compared among viscous cohesive OVDs (OPEGAN Hi(®) 0.85 mL and Healon(®) 0.85 mL) and very low viscosity dispersive OVDs (OPEGAN(®) 0.6 mL and OPEGAN(®) 1.1 mL). Additionally, to exclude the influence of any differences between syringes of viscous cohesive OVDs on the extrusion force, empty syringes of the same configuration were refilled with the same products. In addition, the syringe inner surface and that of the piston attached to the tip of the plunger were measured. RESULTS: The extrusion force of Healon 0.85 mL (3.28±0.19 kgf) was significantly (P<0.01) higher than that of OPEGAN Hi 0.85 mL (2.54±0.23 kgf). The inner syringe chamber for Healon 0.85 mL was vial shaped and had a built-in needle in the Luer tip, which was clearly different from OPEGAN Hi 0.85 mL. There were no significant differences in the extrusion force between refilled syringes. The extrusion force of OPEGAN 1.1 mL (3.44±0.12 kgf) was significantly (P<0.01) higher than that of OPEGAN 0.6 mL (1.63±0.06 kgf). The syringe of OPEGAN 1.1 mL was obviously bigger than that of OPEGAN 0.6 mL. CONCLUSION: It was confirmed that the configuration of the syringes is another determinant of the extrusion force and a factor related to the difference in usability among products that meet the same cohesive class. Dove Medical Press 2014-09-04 /pmc/articles/PMC4160326/ /pubmed/25228786 http://dx.doi.org/10.2147/OPTH.S67689 Text en © 2014 Shiba and Tsuneoka. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Shiba, Takuya
Tsuneoka, Hiroshi
Prefilled syringes and usability of ophthalmic viscosurgical devices
title Prefilled syringes and usability of ophthalmic viscosurgical devices
title_full Prefilled syringes and usability of ophthalmic viscosurgical devices
title_fullStr Prefilled syringes and usability of ophthalmic viscosurgical devices
title_full_unstemmed Prefilled syringes and usability of ophthalmic viscosurgical devices
title_short Prefilled syringes and usability of ophthalmic viscosurgical devices
title_sort prefilled syringes and usability of ophthalmic viscosurgical devices
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160326/
https://www.ncbi.nlm.nih.gov/pubmed/25228786
http://dx.doi.org/10.2147/OPTH.S67689
work_keys_str_mv AT shibatakuya prefilledsyringesandusabilityofophthalmicviscosurgicaldevices
AT tsuneokahiroshi prefilledsyringesandusabilityofophthalmicviscosurgicaldevices